Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02614209 · ClinicalTrials.gov registry record
Blood Collection of Patient Presenting in the ED and Prescribed a BNP
A clinical trial, sponsored by Fujirebio Diagnostics.
- Completed
- Registry status
- 400
- Enrollment target
NCT02614209 is a clinical trial that has completed, run by Fujirebio Diagnostics. The registered enrollment target is 400 participants.
The verdict
NCT02614209 has completed, sponsored by Fujirebio Diagnostics.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
Plasma specimen collected from patients presenting in the Emergency Department (ED) with or without Heart Failure (HF) and prescribed a BNP.
Interventions
- DEVICE In Vitro diagnostic tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02614209
The ClinicalTrials.gov registry entry for NCT02614209 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fujirebio Diagnostics, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which In Vitro diagnostic tests is the first listed.
NCT02614209 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02614209 about?
NCT02614209 is a clinical study titled "Blood Collection of Patient Presenting in the ED and Prescribed a BNP". Plasma specimen collected from patients presenting in the Emergency Department (ED) with or without Heart Failure (HF) and prescribed a BNP.
What is the current status of trial NCT02614209?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2015-05. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02614209?
The interventions under investigation include: In Vitro diagnostic tests (DEVICE).
Who is sponsoring clinical trial NCT02614209?
This trial is sponsored by Fujirebio Diagnostics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.